Clinical Trials

(fostamatinib) – Warm Autoimmune Hemolytic Anemia

A Phase 3, multi-center, randomized, double-blind, placebo-controlled, study of (fostamatinib) Disodium in the treatment of Warm Autoimmune Hemolytic Anemia (wAIHA). The purpose of this study is to assess the safety and efficacy of fostamatinib in subjects with wAIHA.